

Can't find or afford Rybelsus? Explore the best alternatives for type 2 diabetes, including Ozempic, Mounjaro, Trulicity, and Jardiance — with pros and cons.
You've been prescribed Rybelsus for type 2 diabetes, but you can't fill your prescription. Maybe your pharmacy is out of stock. Maybe your insurance won't cover it. Maybe the cost is simply too high without coverage.
Whatever the reason, the important thing is this: you still have options. Several other medications work similarly to Rybelsus and may be available when it isn't.
In this guide, we'll explain what Rybelsus is and how it works, then walk you through four real alternatives your doctor might consider — including their pros, cons, and how they compare.
If your main issue is finding Rybelsus in stock, check out our guide on how to find Rybelsus near you before switching medications.
Rybelsus is the brand name for oral Semaglutide, made by Novo Nordisk. It's a GLP-1 receptor agonist — a class of medications that mimic a natural hormone called glucagon-like peptide-1 (GLP-1).
Here's what GLP-1 does in your body:
Rybelsus is unique because it's the only oral GLP-1 medication available. Most other GLP-1 drugs require injections. That's a significant advantage for patients who are uncomfortable with needles.
For a more detailed explanation, read our article on how Rybelsus works.
Rybelsus is FDA-approved for type 2 diabetes and comes in 3 mg, 7 mg, and 14 mg tablets. For more about uses and dosing, see What is Rybelsus?
Ozempic is the closest alternative to Rybelsus because it contains the exact same active ingredient — Semaglutide. The difference is how you take it: Ozempic is a once-weekly subcutaneous injection using a prefilled pen, while Rybelsus is a daily pill.
Key facts about Ozempic:
Pros:
Cons:
Mounjaro (Tirzepatide) by Eli Lilly is a newer medication that has quickly become one of the most talked-about options for type 2 diabetes. It works on two hormone pathways — GLP-1 and GIP — which is why it's called a "dual incretin" agonist.
Key facts about Mounjaro:
Pros:
Cons:
Trulicity (Dulaglutide) is a well-established GLP-1 receptor agonist that has been on the market since 2014. It's another once-weekly injectable option made by Eli Lilly.
Key facts about Trulicity:
Pros:
Cons:
Jardiance (Empagliflozin) is a different class of diabetes medication — it's an SGLT2 inhibitor rather than a GLP-1 agonist. We're including it here because it's an oral option that many doctors consider when Rybelsus isn't available.
Key facts about Jardiance:
Pros:
Cons:
The best alternative depends on your individual situation. Here are some questions to discuss with your doctor:
Never switch medications on your own. Always work with your doctor to find the right alternative and manage the transition safely.
Not being able to get your Rybelsus prescription filled is stressful, but it doesn't mean you're out of options. Ozempic, Mounjaro, Trulicity, and Jardiance are all effective medications that can help you manage type 2 diabetes when Rybelsus isn't available.
Talk to your doctor, check what your insurance covers, and use Medfinder to find availability near you. Your diabetes management doesn't have to stop just because one medication is hard to find.
For the latest on Rybelsus availability, read our Rybelsus shortage update for 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.